Kyverna Therapeutics, Inc. (KYTX)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-02-14 | 2024-02-12 | B Purchase |
Bain Capital Life Sciences Investors, LLC Large shareholder |
450,000
+16.6%
22.00USD 9,900,000 |
450,000 +16.6% | 22.00 | USD 9,900,000 | |
| 2024-02-14 | 2024-02-12 | B Purchase | Large shareholder |
583
+inf%
22.00USD 12,826 |
583 +inf% | 22.00 | USD 12,826 | |
| 2024-02-14 | 2024-02-12 | B Purchase | Large shareholder |
252,553
+inf%
22.00USD 5,556,166 |
252,553 +inf% | 22.00 | USD 5,556,166 | |
| 2024-02-13 | 2024-02-12 | B Purchase | Large shareholder |
910,000
+28.3%
22.00USD 20,020,000 |
910,000 +28.3% | 22.00 | USD 20,020,000 | |
| 2024-02-12 | 2024-02-12 | B Purchase |
Northpond Ventures III GP, LLC Former 10% Owner |
450,000
+inf%
22.00USD 9,900,000 |
450,000 +inf% | 22.00 | USD 9,900,000 |